During the Annual Open Enrollment Period for Medicare prescription drug coverage (Part D), Medicare beneficiaries are given the opportunity to select a new plan for the upcoming year. The 2027 plan year’s open enrollment period is October 15 – December 7, 2026, with coverage beginning January 1, 2027.
Each year, there are changes to the benefits... Read more
In December 2025, the Centers for Medicare & Medicaid Services (CMS) announced two major initiatives to expand access to obesity management medications for Medicare and Medicaid beneficiaries: the Medicare GLP-1 Bridge program and the BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive Health) Model. CMS has announced an indefinite delay of the BALANCE Model’s Medicare Part D component due... Read more
Enacted in 2022, the Inflation Reduction Act (IRA) introduced significant reforms aimed at reducing the financial burden of prescription drug costs for Medicare Part D beneficiaries.
A new report from MAPRx, however, shows that as a larger share of liability has shifted from the federal government to plans and pharmaceutical manufacturers, plan behavior is seen changing... Read more
The MAPRx coalition has championed policies in Part D that improve the affordability of medications and beneficiary access to those medications, including provisions of the Inflation Reduction Act (IRA) that establish an out-of-pocket cap in Part D and the Medicare Prescription Payment Plan. MAPRx strongly opposes the GUARD Model and urges CMS to abandon this proposal and withdraw the model.... Read more
The Medicare prescription drug benefit (Medicare Part D) has been an enormous help to beneficiaries and a policy success story by providing coverage for prescription drugs. The program filled a major gap in Medicare’s benefits and has done so with consistently high satisfaction among beneficiaries. However, for the MPPP to have a greater impact and operate as intended by Congress... Read more
See the new infographic for changes to the 2026 Medicare Part D program
... Read moreWe are eager to hear about your experiences with the Medicare prescription drug program. We would like to hear about both good and bad experiences that you have had selecting and signing up for a plan, getting your drugs, and paying for your drugs. The form below will allow you to write your story.
Thank you for taking the time to tell us your story.